February 24, 2026

Structure Therapeutics Inc. (GPCR): Analyst Consensus Points to a 60% Upside Potential

Structure Therapeutics Inc. (NASDAQ: GPCR) has captured the attention of investors in the biotechnology sector, primarily due to its innovative approach to addressing chronic diseases with..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Exploring a 17.73% Potential Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) is emerging as an intriguing opportunity for investors within the healthcare sector, particularly those focused on medical care facilities. With..

Biohaven Ltd. (BHVN) Stock Analysis: Navigating a Potential 80% Upside in the Biotechnology Sector

Biohaven Ltd. (NYSE: BHVN) stands as a compelling figure in the biotechnology landscape with a staggering 80.81% potential upside, according to the latest analyst ratings. Specializing..

Arrowhead Pharmaceuticals, Inc. (ARWR): An Investor Outlook on Its 28.86% Potential Upside

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, is capturing investor attention with its substantial growth potential. With a market capitalization of..

Disc Medicine, Inc. (IRON) Stock Analysis: A High-Risk, High-Reward Play with 61.59% Potential Upside

Disc Medicine, Inc. (NASDAQ: IRON) is making waves in the biotechnology sector, capturing the attention of investors with its impressive market cap of $2.42 billion and..

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 36% Potential Upside in the Healthcare Sector

UFP Technologies, Inc. (NASDAQ: UFPT) stands as a noteworthy contender in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $1.86..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Strong Buy Ratings Signal a 57% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands out in the biotechnology sector with a portfolio targeting some of the most challenging neurodegenerative and lysosomal storage diseases. Based..

Azenta, Inc. (AZTA) Investor Outlook: Exploring a 37.95% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector specializing in medical instruments and supplies, has piqued investor interest with a significant potential upside..

Evotec SE (EVO) Investor Outlook: Exploring a 66% Upside Potential in the Drug Discovery Sector

Evotec SE (EVO), a German-based leader in drug discovery and development, is capturing the attention of investors with its potential upside of 66.21% based on current..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 206.86% Potential Upside in the Healthcare Sector

Evolent Health, Inc. (NYSE: EVH) stands at a crossroads of opportunity and challenge, making it a compelling consideration for investors focused on the healthcare sector. With..

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a Promising 47% Upside Potential

ANI Pharmaceuticals, Inc. (ANIP), a prominent player in the healthcare sector, operates within the highly competitive drug manufacturing industry, focusing on both specialty and generic pharmaceuticals...

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: 49.84% Potential Upside in the Biotech Frontier

Viridian Therapeutics, Inc. (NASDAQ: VRDN) is capturing the attention of investors with its impressive potential upside, as the company embarks on a groundbreaking journey in the..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 78.68% Potential Upside in Biotechnology

Vera Therapeutics, Inc. (NASDAQ: VERA), a burgeoning player in the biotechnology sector, has captured the attention of investors with a notable market cap of $2.99 billion..

National HealthCare Corporation (NHC): A Look at Performance Highlights and Market Position in the Healthcare Sector

As an investor, keeping an eye on National HealthCare Corporation (NYSE: NHC) could be a strategic move, especially given its robust presence in the healthcare sector...

Haemonetics Corporation (HAE) Stock Analysis: Exploring a 43.58% Upside Potential

Haemonetics Corporation (NYSE: HAE) is capturing investor attention with its promising potential for a substantial upside. Positioned within the healthcare sector, this Boston-based medical device company..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Exploring a 27% Upside Potential and Robust CNS Portfolio

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector with a focus on central nervous system (CNS) disorders and rare diseases. With a current..

The Pennant Group, Inc. (PNTG): Investor Outlook on a Healthcare Growth Opportunity with a 15% Upside

As investors navigate the healthcare sector, The Pennant Group, Inc. (NASDAQ: PNTG) presents an intriguing opportunity. Headquartered in Eagle, Idaho, this company operates in the medical..

Phreesia, Inc. (PHR) Stock Analysis: A Healthcare SaaS Innovator with a Promising 139.77% Potential Upside

Investors seeking exposure to the dynamic intersection of technology and healthcare might find Phreesia, Inc. (PHR) an intriguing prospect. This Delaware-based company offers a comprehensive SaaS-based..

Kestra Medical Technologies, Ltd. (KMTS) Investor Outlook: Exploring a Promising 8.65% Upside in the Healthcare Sector

Kestra Medical Technologies, Ltd. (KMTS), a pioneering company in the healthcare sector, is capturing investor attention with its innovative wearable medical devices and digital healthcare solutions...

Scholar Rock Holding Corporation (SRRK) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and 7.12% Upside Potential

Scholar Rock Holding Corporation (NASDAQ: SRRK) is capturing investor attention as a promising player in the biotechnology sector, offering innovative treatments for serious diseases. Despite a..

Search

Funds

February 24, 2026

Search

Funds

February 24, 2026

FTSE 100

Funds